Industry Report “Transplant Diagnostics Market Research Report – Global Forecast Till 2023” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Digital Commerce Platform market.
Transplant Diagnostics Market Research Report – Global Forecast Till 2023 to Reach USD 2,074.65 Million and driven by Increasing Numbers of Organ Transplant Procedures; Confirms MRFR
Overview
The global Transplant diagnostics Market is slated to display a CAGR of 7.80% from 2018 to 2023 (forecast period). It can touch a value of USD 2,074.65 million by 2023. The inflow of capital for research and development purposes for improving the accuracy of transplant diagnostic tests can drive the market growth exponentially. Public-private partnerships are likely to expedite the rate of R&D due to subsidies and attractive incentives. Large number of transplantation procedures are likely to elicit the need for transplant diagnostic tests at clinics and hospitals. According to a collaboration between World Health Organization (WHO) and Organización Nacional de Trasplantes, 126,670 organs were transplanted in 2015.
Antibody-mediated refusal of organ allografts is difficult to treat as barriers following allotransplantation. Enhanced diagnostics has permitted better detection and specificity-determination of antibodies precise for a donor Human Leukocyte Antigens (HLA). Nevertheless, antibodies which are also against non-HLA antigens are of importance for graft function. We have established a novel crossmatch test that simplifies detection of donor-specific non-HLA particular antibodies prior to transplantation. Doctors and expert physicians are presently refining this test which allows detection of complement-fixing non-HLA antibodies. Additionally, studies are going on to assess the occurrence of non-HLA specific antibodies in kidney graft inheritors post-transplant as well as at the time of rejection. A substantial problem in clinical transplantation is the lack of donor tissue/organs for transplantation. One of the possible solutions to this problem is the use of tissues/organs/ cells from animals for transplantation to man, which is also known as xenotransplantation. Because xenografts are dynamically rejected, studies on the reasons for this rejection are essential. In particular specialists are interested in evaluating co-stimulation blockade as a means of undertaking long-term pancreatic islet xenograft survival.
Intended Audience
Associations
End Users
Pharmaceutical Companies
Raw Material Suppliers
Suppliers and Distributors
Transplant Diagnostics Kits Manufacturers
Government
Potential Investors
Transplant Diagnostics Market – Segments
By Product & Service: Instruments, Reagents & Consumables, and Software & Services, among others.
By Screening Type : Pre-transplant Screening and Post-transplant Screening, among others.
By Organ Type : Kidney, Liver, Heart, Lung, and Pancreas, among others.
By Application Type : Research Applications and Diagnostic Applications, among others.
By End-user : Commercial Service Providers, Hospitals & Transplant Centers, and Research Laboratories & Academic Institutes, among others.
Leading Market Players
Players leading the global transplant diagnostics market include Illumina, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, F. Hoffmann La Roche Ltd., bioMérieux SA, and QIAGEN NV, among others.
Global Transplant Diagnostics Market Segmented by, Product & Service (Instruments, Reagents & Consumables), Screening Type (Pre-Transplant, Post-Transplant), Organ Type (Kidney, Liver, Heart, Lung, Pancreas), Application Type, End-User
Competitive Analysis:
The increasing incidences of organ failure have generated a high demand for efficient diagnostic procedures which has created a huge opportunity for the players to invest in the global transplant diagnostics market. The players in the global market are focusing on the expansion of their business by increasing the research and development expenditure for new product launch in the global transplant diagnostics market. The strategic mergers and acquisitions are aiding the players to sustain in the highly competitive environment of the global transplant diagnostics market
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services
